| Companies sponsors |
Bayer |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
NHS Bracknell and Ascot CCG |
| |
NHS South Devon and Torbay CCG |
| |
Welsh Government |
| Patient carer groups |
Black Health Agency for Equality |
| |
Bowel Cancer Information |
| |
Bowel Cancer UK |
| |
Cancer Black Care |
| |
Cancer Equality |
| |
Cancer 52 |
| |
Crohn’s and Colitis UK |
| |
Colostomy Association |
| |
Guts UK |
| |
Helen Rollason Heal Cancer Charity |
| |
IA: Ileostomy and Internal Pouch Group |
| |
Independent Cancer Patients Voice |
| |
Macmillan Cancer Support |
| |
Maggie’s Centres |
| |
Marie Curie |
| |
Oesophageal Patients Association |
| |
Pelican Cancer Foundation |
| |
Sarcoma UK |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
Tenovus Cancer Care |
| Professional groups |
Association of Cancer Physicians |
| |
Association of Coloproctology of Great Britain and Ireland |
| |
Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland |
| |
British Geriatrics Society |
| |
British Institute of Radiology |
| |
British Psychosocial Oncology Society |
| |
British Sarcoma Group |
| |
British Society of Gastroenterology |
| |
Cancer Research UK |
| |
Primary Care Society for Gastroenterology |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society and College of Radiographers |
| |
UK Clinical Pharmacy Association |
| |
UK Oncology Nursing Society |
| Assessment group |
Kleijnen Systematic Reviews Ltd |
| Comparator companies |
Accord Healthcare (irinotecan and oxaliplatin) |
| |
Almirall (fluorouracil) |
| |
Hospira UK (fluorouracil, irinotecan, oxaliplatin and raltitrexed) |
| |
medac GmbH (fluorouracil, folinic acid, irinotecan and oxaliplatin) |
| |
Pfizer (irinotecan) |
| |
Seacross Pharmaceuticals (irinotecan and oxaliplatin) |
| |
Servier Laboratories (trifluridine–tipiracil) |
| |
Sun Pharmaceuticals (irinotecan and oxaliplatin) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Scottish Sarcoma Network |
| |
Scottish Society of Gastroenterology |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Bowel Research UK |
| |
Cochrane UK |
| |
Cochrane Upper Gastrointestinal and Pancreatic Diseases Group |
| |
Foundation for Liver research |
| |
Genomics England |
| |
Institute of Cancer Research |
| |
MRC Clinical Trials Unit |
| |
National Cancer Research Institute |
| |
National Cancer Research Network |
| |
National Institute for Health Research |